Changes in PYY and gastric emptying across the phases of the menstrual cycle and the influence of the ovarian hormones by Campolier, M et al.
1 
 
Title: Changes in PYY and gastric emptying across the phases of the menstrual cycle and the 1 
influence of the ovarian hormones 2 
 3 
Authors Names: 4 
Marta Campolier1, Sangeetha PariyarathThondre2, Miriam Clegg3, Amir Shafat4, Ali Mcintosh5, 5 
Helen Lightowler6 (corresponding author) 6 
Authors’ Address and e-mail addresses: 1-3, 5-6 Functional Food Centre, Department of Sport and 7 
Health Sciences, Oxford Brookes University; 4 Physiology, School of Medicine, National University of 8 
Ireland, Galway, Ireland. 9 
 10 
1 marta.campolier-2012@brookes.ac.uk 11 
2 pthondre@brookes.ac.uk 12 
3 mclegg@brookes.ac.uk  13 
4 amir.shafat@nuigalway.ie 14 
5 megazord2@btinternet.com 15 
6 hlightowler@brookes.ac.uk  16 
2 
 
Abstract 17 
Nutrition-related studies avoid the participation of pre-menopausal women due to the potential 18 
effect of the menstrual cycle (MC) on their appetite regulation. It is generally accepted that women 19 
increase their energy intake during the luteal phase (LPh) compared to the follicular (FPh), however 20 
what happens in the menstrual phase (MPh) and how this might be regulated remains uncertain. 21 
Although some research indicates changes in the gastric emptying (GE) velocity, whether PYY is 22 
affected by the MC phase, remains unknown. The aim of this study was to assess whether eating the 23 
same breakfast in each of the three MC phases would change the GE time, the PYY response and 24 
post-prandial satiety such that they might affect subsequent food intake. Furthermore, the aim was 25 
to associate any potential differences to the fluctuations in estradiol (E2) and progesterone (P4) 26 
within a MC. Nine naturally cycling women attended to the laboratory to consume a standardised 27 
breakfast on three occasions, each of them representing one of the MC phases. Breath samples to 28 
measure GE time, plasma samples to quantify PYY levels and hunger scores were collected for a total 29 
of 4 hours after which food intake was assessed by an ad-libitum buffet lunch. GE and PYY levels 30 
changed significantly across the phases of the MC (p <0.05). GE was correlated to P4 and E2-P4 ratio (r 31 
= -0.5 and 0.4, respectively). To conclude, the appetite regulators PYY and GE time change 32 
depending upon the MC phases with GE time associated with the ovarian hormone levels which 33 
suggests the necessity of controlling the MC phase in studies looking at the appetite response.  34 
 35 
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 37 
Abbreviations 38 
AUC Area under the curve 
E2 Estradiol 
EI Energy intake 
FPh Follicular phase 
GE Gastric emptying 
LPh Luteal phase 
MC Menstrual cycle 
MPh Menstrual phase 
P4 Progesterone 
 39 
Tasc Ascension time 
Thalf Half time 
Tlag Lag phase 
Tlat Latency time;  
VAS Visual Analogue Scale 
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Introduction 40 
It is well known that the process of digesting food involves numerous actions by different 41 
organs in order to prepare food for its absorption in the intestine. This action is regulated by 42 
different gastric and intestinal hormones (e.g. gastrin, cholecystokinin (CCK), glucagon-like peptide-1 43 
(GLP-1)) that will ensure the availability of the intestine to continue the digestive and absorptive 44 
process (Smolin & Grosvenor, 1994). Peptide tyrosine-tyrosine (PYY) is one of the multiple regulators 45 
of the digestion process and its main role is to mediate the ileal brake, i.e. the delay in the transit of 46 
the chyme through the gastrointestinal tract (Onaga, Zabielski, & Kato, 2002), that results in an 47 
increase in satiety. Furthermore, its satiating action is also known to originate in the central nervous 48 
system as PYY can cross the blood-brain barrier and target areas known to regulate the homeostatic 49 
e.g. hypothalamus and the hedonic e.g. caudolateral orbital frontal cortex, circuits (Batterham et al., 50 
2007). PYY’s secretion in the distal intestine is stimulated post-prandially and this is related to the 51 
caloric and macronutrient content of the meal (Adrian et al., 1985; Batterham et al., 2003).  52 
Multiple studies have shown how changes in gastric emptying (GE) speed and PYY response to a 53 
meal-test can have an impact on appetite sensations and subsequent food intake (Clegg & Shafat, 54 
2010; Stoeckel, Weller, Giddings, & Cox, 2008). Nevertheless, many of the studies conducted in this 55 
area avoid the participation of women or control their protocol by testing women at a specific phase 56 
of the menstrual cycle (MC), as it is generally accepted that women can experience changes in their 57 
habitual food intake upon the phase of their MC (Buffenstein, Poppitt, McDevitt, & Prentice, 1995; 58 
McNeil & Doucet, 2012). These changes seem to result from a bigger meal size (rather than from an 59 
increased number of meals) in the luteal phase (LPh) than the follicular (FPh) (Asarian & Geary, 60 
2013). Therefore, it could be suggested that women may experience changes in their food intake 61 
due to fluctuations experienced primarily in their satiation (the process of finishing meal), rather 62 
than their satiety (the process inhibiting the start of a meal), throughout the MC.  63 
In fact, Brennan et al. (2009), who assessed food intake from a buffet 90 min after providing a 64 
glucose load to nine healthy women on three days of the MC (two in the FPh and one in the LPh), 65 
found that food and energy intake (EI) during LPh was significantly higher compared to FPh (~50 g 66 
and ~700 kJ difference, respectively). This was related to a faster emptying of the stomach, the time 67 
needed for emptying 50% of the gastric glucose during LPh was 15 min less than during the FPh. In 68 
addition, there was a higher post-meal release of GLP-1, blood glucose and plasma insulin levels in 69 
the LPh, thus the glycaemia response was improved when P4 was low in the FPh. Finally, CCK 70 
response showed no changes despite the differences in hunger and EI between phases. Nevertheless 71 
this was not entirely unexpected as CCK secretion seems to be more affected by fat and protein 72 
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intake rather than glucose (Liddle, Goldfine, Rosen, Taplitz, & Williams, 1985). Whether 73 
modifications in the appetite responses are maintained with a full breakfast and whether there 74 
would be any differences during the menstrual phase (MPh) has not been previously studied. The 75 
latter seems of importance as both ovarian hormones, estradiol (E2) and progesterone (P4), are 76 
found at very low concentrations, in contrast to the other two phases. Having a better 77 
understanding of women’s appetite physiology seems imperative in light of the global higher obesity 78 
prevalence in women than men (WHO, 2015). 79 
The objective of the present study was to assess whether eating the same breakfast in each of 80 
the three MC phases would change the GE time, PYY response and satiety feelings of the meal to 81 
ultimately have an impact on the food intake of a buffet lunch served four hours later. Furthermore, 82 
the aim was to associate any potential differences to the naturally occurring fluctuations in E2 and P4 83 
of the MC. We finally aimed to investigate whether food intake recorded during three days for each 84 
MC phase changed significantly. 85 
 86 
Material and methods 87 
Participants 88 
Participants were recruited by posters placed in Oxford Brookes University facilities e.g. library, 89 
sport centre, student accommodation, and also in local libraries or gyms, as well as on social media. 90 
Moreover, the study was advertised in the Oxford Brookes University Research Activity Group, on 91 
the Functional Food Centre website and in the volunteers section of a local website. 92 
 The inclusion criteria comprised of women between 18-40 y with regular MC for the last three 93 
months that lasted between 25 and 35 days and excluded those who were taking hormonal 94 
contraceptives, were pregnant, lactating or had any metabolic/genetic diseases or taking any 95 
medications known to interfere with their metabolism. In addition, participants who had an 96 
allergy/intolerance to any of the foods given in the study, did not consume breakfast and lunch 97 
habitually or were attempting to lose weight were also excluded. Finally, smokers and participants 98 
with a disease (e.g. Gilbert's syndrome) or taking medication known to interfere with appetite (e.g. 99 
codeine) or those who showed to be restrictive eaters were also excluded. The latter was assessed 100 
by the combination of two adapted restrictive eating questionnaires: the Dutch Eating Behaviour 101 
Questionnaire (DEBQ) (van Strien, Frijters, Bergers, & Defares, 1986) and the Three-factor eating 102 
questionnaire – restraint eating (TFEQ FI) (Stunkard & Messick, 1985). Participants with a TFEQ score 103 
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of >10 and a DEBQ >2.5 were considered restrictive eaters and were excluded from participating in 104 
the study. 105 
Ethical approval for the study was obtained from the University Research Ethics Committee at 106 
Oxford Brookes University. All participants gave written informed consent prior to commencing the 107 
study. 108 
 109 
Protocol 110 
Once the participant agreed to participate in the study, she was given a fertility monitor (Clear 111 
Blue Advanced Fertility Monitor, Clearblue) to assist in the scheduling of visits to the laboratory 112 
based on the three different MC phases i.e. MPh, FPh and LPh. The three chosen days were aimed to 113 
display a very distinguishable profile in the ovarian hormones: MPh, E2 and P4 at low concentrations; 114 
FPh, E2 at high concentrations while P4 remains low; and LPh, E2 and P4 at high concentrations. The 115 
MPh visit was scheduled as soon as the participant notified the start of a new MC (i.e. day 1) and this 116 
was performed within 4 days of starting the MC. From day 6 of the MC, participants tested their 117 
morning urine using the fertility monitor to measure their oestrone-3-glucuronide (E3G) and 118 
luteinising hormone (LH) levels. When participants obtained the ‘high’ reading (i.e. E3G levels were 119 
increased) they notified the researcher who scheduled the next testing session based on the cycle 120 
day of the high reading, the MC length history of the participant and the fact that it usually takes 121 
approximately five days to reach to ‘peak’ after a ‘high’ reading (Howards et al., 2009), in order to 122 
test the participant at very high levels of E2. Once the ‘peak’ reading (i.e. LH levels were high) 123 
appeared, the last session was scheduled to test when P4 was at its highest values (in the mid-luteal 124 
phase) based on the peak day and the usual MC length of the participant. When participants did not 125 
reach ‘peak’ they were asked to postpone their LPh testing session until the next cycle to ensure that 126 
the P4 levels were high enough to produce any potential effects on the parameters studied (i.e. PYY 127 
response, GE time, appetite feelings and food intake). 128 
Once the visit to the laboratory was scheduled, participants were also asked to record their 129 
food intake for three days in each MC phase: (1) the day before coming to the laboratory, (2) the 130 
testing day and (3) the day after the visit to the laboratory. An example testing timeline within a MC 131 
is given in Fig 1. In addition, participants were asked to wear a body monitoring system 132 
(SenseWear®, BodyMedia) to estimate their PA levels to facilitate the validation of the EI from the 133 
food diary and detect any potential misreporting.  134 
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In the evening before each test day, participants were asked to avoid the consumption of 135 
caffeine and alcohol and any strenuous exercise that they would not usually do as part of their 136 
normal daily lifestyle. 137 
 138 
 139 
Fig 1. Example experiment timeline during a MC. 140 
During the visits to the laboratory, participants were requested to arrive between 7:00-9:30h to 141 
have their body composition assessed by electrical bioimpedance, Tanita Body Composition Analyzer 142 
BC-418MA (Tanita Ltd, West Drayton, UK) and then a cannula (BD Venflon Pro Safety 20GA, Becton 143 
Dickinson Induction Therapy, Singapore) was inserted into a vein of the anti-cubital fosse of the arm 144 
to obtain the baseline blood sample (t = 0). The cannula was kept patent by flushing 0.9% sodium 145 
chloride into the system with a needle-free syringe after collecting each sample. Immediately after, 146 
participants filled in the visual analogue scale (VAS) for appetite sensations and the first breath 147 
sample for the measurement of GE was collected. Then the participant consumed the standardised 148 
breakfast labelled with 13C octanoic acid; the breakfast consisted of scrambled eggs on toast, 149 
pineapple and a drink of their choice (water, coffee or tea with/out milk and sugar). The breakfast 150 
was standardised amongst participants and provided 375-395 kcal of which 35%, 38% and 23% were 151 
in the form of fat, carbohydrate and protein, respectively. The energy provided by the breakfast 152 
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accounted for 17-18 % of the total daily energy requirements for an average woman (19-44 years) 153 
with median physical activity level of 1.63 i.e. 2103-2175 kcal/d (SACN 2011). Participants were 154 
asked to finish their breakfast within 15min. As soon as they finished their breakfast, the first post-155 
ingestion breath sample, blood sample and satiety scores were collected. Subsequent breath 156 
samples were taken every 15 min until 240 min. Subsequent blood samples and satiety scores were 157 
taken every 15 min until t = 60 min thereafter every 30 min until t = 240 min (Fig 2). 158 
 159 
Fig 2. Timeline of events during each of the testing days in the laboratory. 160 
Immediately after the last blood sample, the cannula was removed and the participant was 161 
offered an ad-libitum lunch buffet composed by a variety of dishes/foods. The selected foods were 162 
chosen with the aim to satisfy all tastes and possible conditions (e.g. lactose intolerance, vegetarian 163 
diets, etc.) thus food intake was not restrained by choice or quantity (Table 1). Participants were 164 
invited to eat until comfortably full within 30 min.  165 
Table 1. Foods available in buffet lunch with nutritional composition per portion provided. 166 
Food 
Serving Energy Fat 
(g) 
Carbs 
(g) 
Fibre 
(g) 
Prot 
(g) 
Salt 
(g) units g (kJ) (kcal) 
Hummus 
 
50 664 161 14 4 2 4 1 
Apples Gala 1 135 304 71 0 16 2 1 0 
Banana 1 158 636 150 0 36 4 2 0 
Clementines 2 226 398 95 0 20 3 2 0 
Carrots 
 
70 123 30 0 6 2 0 0 
Celery sticks 
 
80 32 8 0 1 1 0 0 
Tomatoes 18 142 119 28 0 4 1 1 0 
Potato Salad * 
 
270 1858 448 35 28 3 4 1 
Tuna & Sweetcorn Pasta 295 2295 549 25 59 3 20 1 
Moroccan Couscous 245 2112 502 16 75 11 9 0 
Bright Salad 
 
83 93 22 0 3 2 1 0 
Cheese, Babybel 4 95 1207 291 23 0 0 21 2 
Low-fat Yoghurt 1 120 406 96 1 19 0 3 0 
Sausages 8 66 779 187 14 7 1 9 1 
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Chicken Nuggets 5 77 770 185 10 14 1 10 0 
Cheese & Tomato Pizza 1 160 1934 459 12 68 2 18 1 
Bread sticks 
 
19 331 78 1 14 1 2 0 
Crisps, ready salted 1 bag 24 527 126 8 12 1 1 0 
KitKat 4 fingers 45 958 229 11 29 1 3 0 
Orange Juice 
 
500 985 230 0 54 0 5 1 
Water 
 
500 0 0 0 0 0 0 0 
Egg Mayonnaise Sandwich * 139 1202 287 13 26 5 14 1 
Chicken Sweetcorn Sandwich* 139 1199 287 12 29 5 14 1 
TOTAL (non-vegan buffet) 3594 17974 4291 184 494 51 142 11 
Bean & Mint Salad ϒ 215 1288 310 13 26 14 15 2 
Soya Fruit Yoghurt ϒ 1 129 396 94 3 12 2 5 0 
Vegetable Spring Rolls ϒ 6 115 1173 281 14 33 3 6 0 
Peanut Butter Sandwich ϒ 113 1477 355 20 23 7 17 0 
Beetroot, Mint hummus Sandwich ϒ 109 755 180 5 23 6 7 1 
TOTAL (vegan buffet)  2914 11413 2721 95 361 62 78 6 
Nutritional composition of the foods was based on manufacturer’s information. Carbs, carbohydrates; 167 
Prot, protein. * Item removed in the vegan buffet. ϒ Item included in the vegan buffet only. 168 
 169 
Measurements 170 
Gastric emptying Breath samples were collected by blowing into a small glass tube (Labco 171 
Exetainer, Labco Limited, UK) through a straw while having the nose blocked with a nose-clip. 172 
Participants blew into the tube while removing the straw to immediately cap the tube which was 173 
then stored at room temperature for analysis. Breath samples were analysed using an isotope ratio 174 
mass spectrometer (ABCA, Sercon Ltd, Chesire UK) to quantify the excess amount of labelled 175 
oxidised octanoic acid (i.e. 13CO2) above baseline for each time point, as previously described 176 
elsewhere (Clegg & Shafat, 2010). This was expressed as the percentage of dose recovered per hour 177 
and this was fitted into a non-linear regression model (Ghoos et al., 1993). From this model several 178 
parameters were measured. Lag phase (Tlag) and half time (Thalf) were calculated using the formulae 179 
derived by Ghoos et al. (1993). Tlag is the time taken to maximal rate of 
13CO2 excretion (Jackson, 180 
Bluck, & Coward, 2004) and is equivalent to the time of the inflection point (Schommartz, Ziegler, & 181 
Schadewaldt, 1998). Thalf is the time it takes 50% of the 13C dose to be excreted (Jackson et al., 182 
2004). Latency phase (Tlat) (Schommartz et al., 1998) is the point of intersection of the tangent at the 183 
inflection point of the 13CO2-excretion curve representing an initial delay in the excretion curve. 184 
Ascension time (Tasc) (Schommartz et al., 1998) is the time course between the Tlat and Thalf, 185 
representing a period of high 13CO2-excretion rates (Fig. 3). 186 
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 187 
Fig 3. GE time points (Clegg & Shafat, 2010) 188 
PYY and E2 and P4 levels. Blood samples were collected with K2E-EDTA tubes (BD Vacutainer, 189 
Becton Dickinson, UK). A 4 ml blood sample was withdrawn from the cannula for every time point, 190 
except for the baseline when 8 ml were collected to measure the ovarian hormones. After collection, 191 
blood samples were kept in ice until they were centrifuged at 4°C for 10 minutes at 4000 rpm (MC-6, 192 
Sarstedt Ltd, Leicester, UK) to extract the plasma. These were then frozen at -80°C in different 193 
aliquots until analysis. E2 and P4 levels were measured by an ElectroChemiLuminescense 194 
immunoassay (ECLIA) with a Cobas e411 semi-automated analyser (Roche diagnostics Burgess Hill, 195 
UK) and total PYY concentrations were assessed with a direct sandwich enzyme-linked-196 
immunosorbent assay (ELISA) kit (EMD Millipore).  Samples of the same participant in the three 197 
phases of the MC were analysed within the same ELISA plate. Averaged intra-duplicates coefficient 198 
of variance (CV) for the total PYY ELISA assay was 6.3 ± 1.4 %. Averaged inter-plate CV for the quality 199 
controls of the PYY ELISA assay was 13.3 ± 4.1 %. 200 
Appetite sensations. Feelings of satiety were assessed by four questions (1) ‘How hungry do you 201 
feel?,’ (2) ‘How full do you feel?’, (3) ‘How strong is your desire to eat?’ and (4) ‘How much food do 202 
you think you can eat?’ in which participants had to rate their appetite sensations with the VAS, 203 
namely, by putting a mark in a 100 mm line per each question, where 0 = (1) ‘not hungry at all’, (2) 204 
‘extremely full’; (3) ‘not strong at all’ and (4) ‘nothing at all’ and 100 = (1) ‘extremely hungry’, (2) ‘not 205 
at all full’; (3) ‘extremely strong’ and (4) ‘a large amount’. The distance between the origin (score = 0) 206 
and the mark was used to measure the participant’s score.  207 
Ad libitum food intake. The researcher weighed out all the foods before and after the 208 
participant had lunch and then food intake was analysed using an excel spreadsheet designed from 209 
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the manufacture’s food information provided in the food label. Ad-libitum food intake assessment 210 
included the measurement of energy, carbohydrate, protein, sugar, fat, saturated fat, fibre and 211 
sodium.  212 
Food intake from food diaries. For three days of each MC phase participants were asked to 213 
weigh out and record all the foods and beverages consumed with as much detail as possible (e.g. 214 
brand, cooking process). If participants could not weigh out a meal, they were asked to provide 215 
portion sizes by using household measures (e.g. cups) and/or by taking pictures of the foods eaten. 216 
The selected days of each phase included one of the visits to the laboratory (on day 2 of the 3-days), 217 
therefore participants had to only record anything consumed after leaving the testing facilities on 218 
the test day. Food intake recorded was measured by the use of a nutrition analyses software 219 
program (Nutritics V3.74 Professional Edition) and intakes of energy, carbohydrate, sugar, protein, 220 
fat, saturated fat, fibre and sodium were determined per day and per phase of the MC for each 221 
participant.  222 
Physical activity. Participants were requested to wear the body monitoring system on the upper 223 
right arm (triceps muscle) throughout the day (24 hours) except during activities in which the skin is 224 
in contact with water (e.g. showering) as the equipment instructions advise (Body Media, 2006). 225 
Data was downloaded and analysed as total daily energy expenditure (kcal/d) using the BodyMedia 226 
software once individual characteristics (i.e. date of birth, height, weight, sex) were entered into the 227 
system. Averaged daily energy expenditure across the same nine days as the food diaries were 228 
recorded. This was then compared to the energy intake estimated from the food diaries. 229 
 230 
Calculations and statistical analyses 231 
PYY peak was defined as the highest PYY concentrations achieved post-baseline. Concentrations 232 
of PYY were used to calculate the total area under the curve (AUC) using the trapezoidal method at 233 
min 60, 120, 180, 210 and 240 from baseline (before breakfast).  234 
Each appetite sensation question was analysed separately by calculating the derived AUC from 235 
the scores of all the time points. AUC was calculated using the trapezoidal method at min 60, 120, 236 
180, 210 and 240 from baseline. The employment of VAS has been validated in many studies and the 237 
use of total AUCs with baseline levels as covariates has been recommended over individual time 238 
scores or incremental AUCs within participants (Blundell et al., 2010). 239 
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One-way repeated measures ANOVA or Friedman test was used to test differences across the 240 
phases of the MC for PYY AUCs, ovarian hormone levels, GE parameters and food intake across the 241 
phases of the MC. When significant differences were found, a Bonferroni post-hoc pairwise 242 
comparison or a Wilcoxon signed-rank test was performed, according to the normality of the data. A 243 
2-way repeated measures ANOVA with time and MC phase as factors was used to analyse the 244 
change in PYY levels from baseline within subjects as an assessment of the post-prandial changes 245 
across the MC. AUC for VAS was analysed with another 2-way repeated measures ANOVA that 246 
included the baseline scores as covariates in the analyses.  247 
Associations between EI and PYY, GE and appetite feelings as well as between ovarian 248 
hormones and the appetite markers (i.e. EI and PYY, GE and appetite feelings) were analysed by 249 
Pearson’s or Spearman’s correlation, according to the normality of the data.  250 
A sample size of nine women was based on the only other study that has looked at appetite 251 
hormones responses in the MC (Brennan et al., 2009). 252 
 253 
Results 254 
Participants characteristics 255 
Fifteen women signed the consent form of which three had to be excluded because of violating 256 
the inclusion criteria (i.e. irregular MC and suspicion of suffering Gilbert’s syndrome). Of the twelve 257 
women who started the study, two withdrew due to personal reasons and another who completed 258 
the study had to be excluded because of unconfirmed ovulation and unavailability to reschedule the 259 
LPh testing day. Thus the following results are based on a population of nine NC women (Table 2). 260 
Table 2. Participants’ characteristics at baseline 261 
 Mean ± SD 
Age (years) 31 ± 6 
Height (m) 1.67 ± 0.09 
Body weight (kg) 63.4 ± 12.8 
BMI (kg/m2) 22.6 ± 2.7 
Fat Mass Percentage (%) 29.0 ± 7.4 
Fat Mass (kg) 19.1 ± 7.8 
Fat Free Mass (kg) 44.4 ± 6.3 
Waist-to-hip ratio 0.77 ± 0.07 
 262 
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MC characteristics and ovarian hormones 263 
Average MC length was 29 ± 3 days. Of the nine participants included, four had a “peak” reading 264 
i.e. ovulation was confirmed by the fertility monitor, within their first MC, while three participants 265 
only ovulated on the second MC. Averaged “peak” reading happened on day 14 ± 3 of the MC. The 266 
two remaining participants were asked to attend to the laboratory when it was expected to be their 267 
mid-LPh despite not having had a peak reading in the fertility monitor. Nevertheless, plasma P4 268 
levels indicated that these participants had ovulated as P4 concentrations were > 15.9 nmol/L which 269 
is considered high enough to have ovulated (Piers et al., 1995). Moreover, one of these two 270 
participants had a positive LH peak in her personal fertility monitor, thus participants were kept in 271 
the study as they seemed to have ovulated despite not having been detected by the fertility monitor 272 
used in the study. 273 
There were significant differences in E2 and P4 concentrations amongst the three phases of the 274 
MC (p < 0.001 and <0.0001, respectively). E2 levels were significantly increased in the FPh and LPh 275 
compared to the MPh, and P4 levels were significantly higher in the LPh compared to the other two 276 
phases (Fig 4).  277 
 278 
Fig 4. E2 and P4 concentrations in the different phases of the MC (means ± SD). 279 
 280 
GE  281 
There was a significant overall effect of the phase of the MC on Thalf and Tasc (Table 3) but none 282 
of the specific comparisons between phases indicated a significant difference. However the effects 283 
observed seem to suggest trends that Thalf was quicker in the LPh compared to the FPh and the MPh 284 
0
10
20
30
40
50
60
0
200
400
600
800
1000
MPh FPh LPh
P
4
 (
n
m
o
l/
L)
 
E2
 (
p
m
o
l/
L)
 
E2 (pg/ml) P4 (ng/ml)
p = 0.001 
p = 0.001 
p = 0.008 
p = 0.008 
13 
 
(mean difference: 28 ± 31 and 13 ± 15 min, p = 0.081 and 0.092, respectively) and Tasc was faster in 285 
the LPh compared to the FPh (mean difference: 27 ± 29 min, p = 0.077). There was a trend towards a 286 
difference in Tlag across the phases of the MC (p = 0.072). No differences were found in Tlat across the 287 
phases of the MC. 288 
Table 3. GE parameters shown in minutes for MPh, FPh and LPh. 289 
GE parameter (min) MPh FPh LPh p 
Thalf 101 ± 23 116 ± 46 88 ± 22 0.015 
Tlag 48 ± 8 51 ± 14 43 ± 12 0.072 
Tlat 52 ± 7 53 ± 12 48 ± 13 0.264 
Tasc 128 ± 23 143 ± 41 116 ± 13 0.011 
Thalf, half time; Tlag, lag phase; Tlat, latency time; Tasc, ascension time. Mean ± SD 290 
 291 
Total PYY 292 
Due to blood collection issues, a total of four samples (1%) could not be obtained. These were 293 
the 150-240 min samples of one participant’s FPh, therefore, comparisons from min 150 onwards 294 
are only from 8 participants.  295 
PYY levels were significantly different at baseline across the phases of the MC (p = 0.004), being 296 
significantly lower in the LPh compared to the MPh (14.97 ± 10.11 vs 22.81 ± 11.89 pmol/L) (p = 297 
0.008), but not to the FPh (16.22 ± 7.08 pmol/L, p = 0.079). PYY peak was lower in the LPh compared 298 
to the MPh and FPh (29.20 ± 12.38 vs.33.35 ± 11.83 and 32.94 ± 12.00 pmol/L, respectively) but it 299 
was not significantly different (p = 0.264). 300 
There was a significant overall effect on PYY AUC at t = 60, 120, 180 and 240 min, but only at t = 301 
60 min there was a significant difference between specific phases, i.e. LPh vs. MPh (1157 ± 678 302 
vs.1471 ± 650 pmol/ml/min) (p = 0.021) (Fig 5). However the effects observed seem to mainly reflect 303 
that the PYY AUCs at t = 120, 180 and 240 min were smaller in the LPh compared to the MPh (p = 304 
0.066, 0.129 and 0.113, respectively).  305 
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 306 
Fig 5. Total PYY AUCs at t = 60, 120, 180 and 240 min in the different phases of the MC (means ± 307 
SD). *Significantly different to the LPh within the same time AUC. 308 
The 2-way ANOVA analyses looking at the change in PYY levels from baseline to every time 309 
point showed that only time had a significant effect (p <0.001), whereas phase or phase x time 310 
interaction had no statistical effect on PYY change (p = 0.846 and 0.213, respectively) (Fig 6). 311 
 312 
Fig 6. Change in PYY levels from baseline to each time point in the different phases of the MC 313 
(Means ± SD). 314 
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Satiety ratings 316 
There were no significant differences in AUC for any of the four satiety questions when 317 
analysing them in a two-way-ANOVA (time x phase) with the baseline measurements as covariates. 318 
AUC at the end of the 4 hours test for “how hungry do you feel”; “how full do you feel?” “how strong 319 
is your desire to eat” and “how much food do you think you can eat?” were 6932 ± 2961, 7404 ± 320 
2010 and 7802 ± 2080 mm/min; 8924 ± 3153, 10358 ± 4261 and 10340 ± 3638 mm/min; 7039 ± 321 
3147, 7479 ± 2108 and 8268 ± 2388 mm/min for MPh, FPh and LPh, respectively (Fig 7). 322 
Fig 7. Appetite sensations scores (mm) before and after breakfast in the different phases of the 323 
MC: (1) ‘How hungry do you feel?’ (A), (2) ‘How full do you feel?’ (B), (3) ‘How strong is your desire to 324 
eat?’ (C) and (4) ‘How much food do you think you can eat?’ (D). (Means ± SD) 325 
 326 
  327 
a 
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Ad-libitum, post-lunch and averaged food intake  328 
For this section of the results, a participant’s data was excluded as her eating behaviour and 329 
food diary analyses showed a strong indication that she was restricting her EI during the ad-libitum 330 
buffet-lunch as well as underreporting her food intake in the food diary.  331 
During the buffet lunch there were no significant differences in EI, carbohydrate, protein or fat 332 
intake between phases of the MC (Table 4). Similarly no differences were observed in food intake 333 
once participants left the laboratory. In addition, as an average of the three days in each MC phase, 334 
non-significant differences were found in food intake. Finally, food intake as an average of the day 335 
before and after the laboratory visit, i.e. food intake under free-living conditions, did not change 336 
significantly for energy, carbohydrate, fat or protein intake across the MC. 337 
Table 4. Food intake during and after the ad libitum lunch and as an average of the three 338 
measured days in each MC phase. 339 
  MPh FPh LPh 
Ad libitum lunch 
Energy (kcal) 931 ± 193 984 ± 178 956 ± 194 
Carbohydrate (g) 113 ± 20 119 ± 20 116 ± 27 
Fat (g) 38 ± 11 41 ± 10 39 ± 8 
Protein (g) 29 ± 6 30 ± 6 30 ± 7 
    
After Ad libitum lunch 
Energy (kcal) 1131 ± 339 1308 ± 660 1192 ± 485 
Carbohydrate (g) 134 ± 47 156 ± 93 141 ± 54 
Fat (g) 42 ± 14 52 ± 25 56 ± 31 
Protein (g) 43 ± 21 39 ± 16 34 ± 18 
    
Average of 3 days 
Energy (kcal) 2352 ± 358 2368 ± 604 2443 ± 412 
Carbohydrate (g) 271 ± 41 274 ± 70 279 ± 54 
Fat (g) 101 ± 21 97 ± 25 106 ± 22 
Protein (g) 84 ± 17 77 ± 10 85 ± 15 
    
Free-living conditions    
Energy (kcal) 2292 ± 146 2203 ± 598 2386 ± 520 
Carbohydrate (g) 264 ± 52 255 ± 64 270 ± 67 
Fat (g) 103 ± 26 91 ± 26 103 ± 27 
Protein (g) 79 ± 19 70 ± 13 84 ± 20 
Means ± SD 340 
  341 
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Relationships between PYY, GE, appetite feelings and EI 342 
There was a significant moderate correlation between peak PYY and Thalf and Tasc (r = 0.396 and 343 
0.410, p = 0.041 and 0.034, respectively). Moreover, there was a trend for a moderate correlation of 344 
PYY AUC at time 180 and 240 with Thalf and Tasc (r = 0.4 for all, p = 0.08 and 0.07 for Thalf and Tasc 345 
correlations, respectively).  346 
No significant correlations were found between EI and PYY, GE or appetite feelings. 347 
 348 
Relationships between appetite markers and the ovarian hormones  349 
There was a moderate negative correlation between Thalf and Tasc and P4 levels (r = -0.490 and -350 
0.426, p= 0.010 and 0.027, respectively). Moreover, Thalf and Tasc were positively correlated to E2:P4 351 
ratio (r = 0.437 and 0.407, p= 0.023 and 0.035). 352 
There were no correlations between PYY AUCs or peak PYY and the ovarian hormones.  353 
Similarly, no correlations between appetite sensations or food intake and the ovarian hormones 354 
were found. 355 
 356 
Discussion 357 
The aim of this study was to investigate whether appetite responses vary after consuming the 358 
same breakfast in the different phases of the MC. This research is of importance in order to extend 359 
the current knowledge in appetite regulation in a subset of the adult population who seems to be at 360 
a higher risk of developing obesity than men (WHO, 2015). 361 
Our results showed that the time to empty half of the breakfast from the stomach to the 362 
duodenum (Thalf) was significantly different across the phases of MC, being on average 28 and 13 363 
minutes quicker in the LPh compared to the FPh and MPh, respectively. It could be suggested that 364 
the reduction in the GE time (represented by Thalf) was because of a significantly shorter Tasc and, 365 
potentially, a faster Tlag in the LPh compared to the other phases.. In the LPh, high GE rates might 366 
have been reached quicker and once attained, these were sustained for a shorter period which 367 
resulted in a reduction of the time required to empty the same amount of food from the stomach 368 
when compared to the other two phases of the MC. Because Tasc was maintained for less time in the 369 
LPh, GE rates achieved during that period had to be of a higher velocity to achieve a shorter Thalf. 370 
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Faster GE during the LPh in comparison to the FPh has previously been described (Brennan et 371 
al., 2009), however, others have found opposite results (Gill, Murphy, Hooper, Bowes, & Kingma, 372 
1987) or no differences (Horowitz et al., 1985; Monés et al., 1993) between these two phases, thus a 373 
definite position in this matter cannot be made with the available evidence. Discrepancies amongst 374 
studies might be due to different test meals in terms of calories and nutrient composition (Horowitz 375 
et al., 1985) and the fact that some women might not have ovulated as this was not tested in all 376 
studies (Monés et al., 1993). Furthermore, attention is warranted as our outcome does not only 377 
support those who found differences between the LPh and the FPh (Brennan et al., 2009), but also 378 
suggests that the GE effect seen in the LPh is large enough to be compared to the MPh, as well. As 379 
far as we know, this is the first study to add the MPh as another time point to investigate GE within 380 
the MC and our findings suggest that this should be included in future investigations. 381 
To our knowledge, this is the first investigation to indicate that fasting and post-prandial PYY 382 
levels significantly change amongst the phases of the MC. The results indicate that when participants 383 
are fasted in the LPh there are lower PYY levels compared to the MPh. Moreover, the results suggest 384 
that PYY response is smaller after the consumption of the same breakfast in the LPh compared to 385 
the other MC phases. Nevertheless, the MC effect on the PYY response seems to partly result from 386 
the significant differences found at baseline (when fasted) as the statistical significance was lost 387 
when looking at the change in PYY levels from baseline. 388 
PYY secretion occurs by direct contact depending on the presence of food in the lower intestine 389 
(ileum, colon) where the L-cells are located (Fu-Cheng et al., 1995). Its secretion can also start earlier 390 
via neural or hormonal mechanisms, by digestive events that occur at upper sections of the 391 
gastrointestinal tract, i.e. duodenum and stomach (Fu-Cheng et al., 1995). For instance, there is 392 
evidence that gastrin, which is known to stimulate the production of gastric acid, can inhibit the 393 
release of PYY as seen in rats (Gomez et al., 1996). Meanwhile, the increase in gastric acid 394 
concentrations will trigger the synthesis of PYY as part of the ileal brake of the digestion process, 395 
thus creating a feedback loop between the upper and lower gastrointestinal tract. In some 396 
(Adamopoulos, Dessypris, Xanthopoulos, & Chryssicopoulos, 1982) but not all (Frick, Bremme, 397 
Sjögren, Lindén, & Uvnäs-Moberg, 1990; Uvnäs-Msoberg, Sjögren, Westlin, Anderson, & Stock, 1989) 398 
studies, gastrin levels were elevated in the LPh when compared to the FPh which could partly 399 
explain the impairment in the PYY release and the consequent unavailability to reduce the GE time 400 
in the LPh in our participants. This was supported by the positive correlation found between Thalf and 401 
PYY peak and the tendency for a positive correlation with the PYY AUC at t = 180 and 240 min.  402 
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Another potential mechanism that could have contributed to the different PYY responses would 403 
be changes in the CCK secretion. CCK release after the infusion of long-chain fatty acids in the 404 
duodenum has been shown to up-regulate PYY secretion by CCK-receptor 1 (Degen et al., 2007), thus 405 
if CCK secretion is inhibited in the LPh that could in turn impair PYY release. Brennan et al. (2009) 406 
found that CCK secretion was maintained across the MC, although this could have been influenced 407 
by the fact that participants only ingested a glucose drink and carbohydrates are known to be less 408 
effective in stimulating the CCK than fats (Hildebrand et al., 1990), thus there could still be a 409 
potential for CCK modulating the changes in PYY secretion across the phases of the MC. 410 
One interesting finding of the current study was the significant negative correlation between P4 411 
and Thalf. Despite being only a moderate correlation, our results agree with Brennan et al. (2009) and 412 
corroborate the idea that the ovarian hormones might have an influence on GE. Furthermore, the 413 
fact that the ratio between E2 and P4 is also significantly correlated, suggests that both hormones 414 
may modulate the changes in the GE process. Although our results did not indicate a direct 415 
association between PYY levels and the ovarian hormones, these may have exerted their influence 416 
by other factors involved in the digestive process e.g. GE, other appetite-hormonal secretions. 417 
Considering the naturally occurring changes in E2 levels between the MPh and FPh it seemed 418 
necessary to investigate three rather than two phases and this was corroborated by the outcome of 419 
the study. 420 
 Although increases in food intake in the ad-libitum lunch were expected in the LPh as seen in 421 
previous literature (McNeil & Doucet, 2012), our results did not find significant fluctuations in EI or 422 
macronutrient intake across the phases of the MC. This could be due to the fact that the majority of 423 
the food intake of the day (while in the laboratory) was already purposely kept constant, thus 424 
leaving little room for any changes. Nevertheless, food intake under the free-living conditions, which 425 
was 183 and 94 kcal/d higher in the LPh compared to the FPh and MPh, respectively, was not 426 
significantly different throughout the MC phases, either. Despite not reaching the statistical 427 
significance, fluctuations were within the spectrum of +50-100 kcal/d which are recognised to be of 428 
enough magnitude to induce the progressive development of obesity (Mozaffarian, Hao, Rimm, 429 
Willett, & Hu, 2011).   430 
The unchanged food intake during the lunch buffet may be expected since there were no 431 
significant differences in the appetite sensations post-breakfast, suggesting that food intake was 432 
responding to actual appetite perceptions and not to other extrinsic factors. However, direct 433 
correlations were not found between food intake and appetite sensations which manifest the 434 
difficulty in assessing subjective measurements.  435 
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Although the assessment of food intake in a controlled setting presents important advantages, 436 
such as the availability to accurately quantify what is consumed, it also presents several limitations 437 
that cannot be ignored. For instance, eating behaviour can be altered due to eating in a non-familiar 438 
and unnatural environment, or because of the expectations the participants believe that the 439 
researcher might have (Stubbs, Johnstone, O’Reilly, & Poppitt, 1998). Nevertheless, we tried to 440 
minimise this effect by providing a sensible variety of foods that the participant could be familiar 441 
with. On the other hand, although food diaries can avoid the limitations of the laboratory setting, 442 
they can also present different drawbacks such as the misreporting displayed by one of our 443 
participants as well as in other studies (de Vries, Zock, Mensink, & Katan, 1994). Therefore, both 444 
methods agreed on the idea that there were no significant alterations in food intake throughout the 445 
phases of the MC. Inconsistencies with other studies might rely on the limited sample size, although 446 
others have proved significant differences with the same number of participants (Dalvit-McPhillips, 447 
1983). Thus, differences between the latter study and ours could partly be due to the dietary 448 
assessment techniques employed i.e. dietary interview during 60 days vs. 9 days of food diaries. 449 
Finally, although PYY response significantly changed throughout the MC, the magnitude of the 450 
change (mean difference in total PYY AUC at min 240 in LPh: 15 and 23% compared to the MPh and 451 
FPh, respectively) might not have been substantial enough to elicit modifications in appetite 452 
sensations and subsequent food intake. 453 
There were limitations to this study. Despite GE time and PYY response showing to be 454 
significantly different across the MC, pairwise comparisons could not achieve the statistical 455 
significance and that could be due to the small sample size or the inter-individual variation. In fact, if 456 
applying a t-test to compare Thalf between the LPh and FPh or MPh, significant differences would 457 
have been found; however, with the ANOVA and the Bonferroni correction, the statistical 458 
significance was diminished. Nevertheless, we employed the same sample size used by previous 459 
studies (Brennan et al., 2009). The current study did not distinguish the two different forms of PYY, 460 
i.e. PYY1-36 and PYY3-36. It is well known that with food intake PYY1-36 is cleaved by the dipeptidyl 461 
peptidase IV to PYY3-36 and that only the latter form has almost exclusive and high affinity to Y-2 462 
receptors of the ARC. This is of relevance as Y-2 receptors are the only subtype of Y-receptors that 463 
can induce appetite and body weight suppression by stimulating the activity of the α-MSH through 464 
the inhibition of the NPY release (Ballantyne, 2006). Thus, although unlikely, changes in the 465 
concentrations of total PYY could respond to alterations in the proportion between the two forms of 466 
PYY. Thus it cannot be dismissed that lower PYY response in the LPh was mainly relying on a 467 
diminished PYY1-36 secretion and conversion, therefore, inducing minimal changes in food intake. 468 
Future studies could improve our findings by measuring the two forms of PYY. 469 
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 470 
Conclusion 471 
To our knowledge this is the first study to investigate GE time and PYY response after 472 
consuming the same breakfast three times in the MC in which ovarian hormones, E2 and P4 473 
presented very distinguishable levels. Our results found significant differences in GE time and PYY 474 
response that suggest the LPh as the quickest in GE time with the smallest PYY response of the all 475 
MC phases.. Finally changes in the GE time could be influenced by the fluctuations in the ovarian 476 
hormones. 477 
Further research needs to be done to confirm these findings and to have a better understanding 478 
of the underlying mechanisms for these changes in GE time and PYY response across the MC as they 479 
could potentially direct us to novel dieting strategies in women. Finally, our findings suggest that any 480 
functional food studies aimed to change satiation should take into account the likely modifications in 481 
the processing of food that women might experience throughout the MC by re-testing their products 482 
in the different MC phases to ultimately be able to demonstrate the effects of a dietary intervention 483 
in this population. 484 
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